EPILEPSYGTX
HQ - Canterbury
Summary
EpilepsyGTx is a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 25 M
Avg. Deal Size£ 25 M
All rights reserved. Copyright © 2025 Datasite
